Refine by MP, party, committee, province, or result type.

Results 1-15 of 23
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  To answer the first question, I think that as the length of time the reactor was down progressed, we would have stabilized on the amount of technetium and molybdenum that we were able to get. I think we would have maximized what we could get from the worldwide supply, so we would

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  To answer the first question, I do not know why they disbanded the committee. The answer to the second one is yes, I think it would be very good for us to have an advisory committee with some nuclear medicine specialists on the CNSC to help them evaluate the medical needs. That

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  Yes. I think the need for better communication is apparent in the way we handle the patients and how we can triage the patients. If we know in advance, we can do two things. All physicians can look at their patient workload and triage appropriately. They can speak with other moda

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  Taking into consideration what I've said in the past about my qualifications, essentially there are a small number of patients who require nuclear medicine scans who have a 20 percent to 30-some percent risk--and I'm taking this from Dr. O'Brien--of further consequences, patients

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  We would have seen a continued decline in services throughout Canada in the areas that could not be supplied by alternate suppliers. So everywhere in Canada that was supplied solely by Bristol-Myers Squibb would have been cut back to the levels they were able to get through Brist

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  Definitely.

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  As I said, I don't know if I can restate the dire consequences of death, but I can certainly go back to what Dr. O'Brien said, and he felt unequivocally that was the case.

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  I can't answer that one way or the other. It's a very complicated answer to that question, and take this from me in my current position. Most of the nuclear medicine tests are diagnostic in nature. They inform physicians what they need to do to give the best care possible for tha

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  With respect to outrage, most professionals don't run around yelling at people, because it doesn't help at all.

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  I think if you had been privy to the board meetings of the CSNM, the CANM, CARS, CCRS , and the ad hoc committee, you would know that it was made abundantly clear that we were very concerned about communication. One of the things we would like to implement in the future is a bett

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  I've never been asked that question before. I will go back to my board and find out.

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  Indeed.

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  I think we were aware that there would be an adverse effect on patient care probably at the beginning of the week of December 10 or 11--that Monday--whatever day that was. We started getting phone calls that week from a lot of the centres that were solely supplied by Bristol-Mye

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  That's a difficult question for me to answer. I'm not a physician, so it is best for me to leave the specifics of that to the physicians. But I do know, through my colleagues, that the information given by Dr. Gulenchyn , Dr. O'Brien, Dr. MacEwan, and some others we discussed it

February 12th, 2008Committee meeting

Douglas Abrams

Health committee  The situation with radioisotopes is maybe a bit more unique than other pharmaceuticals, in that we are often subject to delays, as has been mentioned. The radioisotopes actually go out of Canada to the United States and then back into Canada, which is another discussion all by it

February 12th, 2008Committee meeting

Douglas Abrams